Less Ads, More Data, More Tools Register for FREE

Pin to quick picksADMR.L Regulatory News (ADMR)

  • There is currently no data for ADMR

Cancellation of Listing

16 Aug 2024 07:00

RNS Number : 6768A
Acuren Corporation
16 August 2024
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

For immediate release

Acuren Corporation (formerly known as Admiral Acquisition Limited)

CANCELLATION OF LISTING ON THE OFFICIAL LIST AND TRADING ON THE LONDON STOCK EXCHANGE

16 August 2024 - Acuren Corporation (formerly known as Admiral Acquisition Limited) (LSE: ADMR / ADMW) (the "Company") announces that further to its announcement of 30 July 2024, the Company confirms that it expects the cancellation of the listing of its ordinary shares and warrants from the Official List of the Financial Conduct Authority and the cancellation of the admission to trading of its ordinary shares and warrants from the Main Market of the London Stock Exchange will take effect from 8:00 a.m. (London time) on Monday, 19 August 2024.

About Acuren

Acuren is a leading North American provider of critical asset integrity services. Acuren provides mission critical, regulatorily-mandated, nondestructive testing, inspection and engineering & lab testing services across a variety of industrial end markets. Acuren operates across three service lines: Nondestructive Testing ("NDT"), Rope Access Technician solutions ("RAT") and Engineering and Lab Testing. NDT offerings include breadth of nondestructive testing services including conventional, advanced and tech-enabled NDT. RAT offerings include a full suite of rope access technician offerings including inspection, repair and specialty craft services. Engineering and Lab Testing offerings include materials engineering and lab testing services.

Enquiries:

Ed Hammond

ed@collectedstrategies.com

(917) 346-6841

 

Dan Moore

dan@collectedstrategies.com

(201) 675-0906

Legal Entity Identifier (LEI): 213800ZDFRNC8QXEZ481

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCQKPBNDBKBNFD
Date   Source Headline
16th Aug 20247:00 amRNSCancellation of Listing
8th Aug 202411:38 amRNSHolding(s) in Company
2nd Aug 20241:50 pmRNSPDMR/PCA Notifications
31st Jul 20243:17 pmRNSTotal Voting Rights and Share Capital
30th Jul 20245:33 pmRNSAcquisition of Acuren completed
30th Jul 20248:00 amRNSSuspension of Securities
30th Jul 20247:30 amRNSSuspension - Admiral Acquisition Limited
19th Jul 20243:10 pmRNSAnticipated completion date of Acuren acquisition
10th Jul 20244:18 pmRNSSyndicated debt offering & Acuren Q1 results
5th Jul 20243:24 pmRNSWarrant Financing & Consent Solicitation Update
19th Jun 20247:00 amRNSWarrant Financing & Consent Solicitation Update
28th May 20243:15 pmRNSLaunch of Warrant Financing & Consent Solicitation
22nd May 20247:00 amRNSAcquisition of Acuren
19th Feb 20247:00 amRNSAnnual Report and Financial Statements
5th Jan 20244:42 pmRNSHolding(s) in Company
23rd Aug 20237:00 amRNSInterim Report and Financial Statements
26th May 202311:10 amRNSHolding(s) in Company
25th May 20233:43 pmRNSHolding(s) in Company
22nd May 20237:00 amRNSAdmission to Trading on the London Stock Exchange
17th May 20235:15 pmRNSPublication of Prospectus
17th May 20237:00 amRNSInitial Public Offering

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.